Explore professionally built ETF model portfolios. Discover now →

Advertisement
Advertisement

KraneShares MSCI All China Health Care Index ETF

This ETF provides exposure to Large and Mid-Cap Chinese Health Care Equities

KURE performance and flow charts

Last update 10/30/2026 at 1:30 PM
Live
Closed
Last price
$17.62
-$0.18 (-1.01%) Yesterday

Performance

-10.0-8.0-6.0-4.0-2.00.0%Sep 30Oct 7Oct 14Oct 21Oct 28

Flows

0 M2 M4 M6 M
1 day price range
$17.50
$17.69
52 week price range
$14.59
$20.01
1W perf
-1.57%
YTD perf
+2.21%
YTD flows
+$29M
AuM
$108M
E/R
0.79%
TTM yield
4.07%
Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

Historic performance and flows

Data as of October 30, 2026
1M3MYTD1Y3Y5Y
Perf.-9.54%+2.04%+2.21%-3.71%+0.48%-38.67%
Flows+$5M+$8M+$29M+$16M+$39M-$12M
Data as of October 30, 2026
Advertisement

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Characteristics

The KraneShares MSCI All China Health Care Index ETF is built to track the MSCI China All Shares Health Care 10/40 Index - USD. This ETF provides physical exposure - by owning its shares you earn the return of the securities composing the index (as the ETF holds them directly). This share class generates a stream of income by distributing dividends.

Management strategyPassive
StrategyLong Only
ProviderKraneShares
N° of holdings42
Replication methodDirect (Physical)
Asset classEquity
Dividend policyDistributing
Trailing 12m distribution yield
Join for free
Inception dateJanuary 31, 2018
ESGNo
TrackinsightTrackinsight

More data and info about KURE on Trackinsight

Exposure

Data as of September 30, 2026

Diversification

68.44%

Total weight of top 15 holdings out of 42

Top 15 Holdings

BeOne Medicines Ltd.
8.83%
Innovent Biologics, Inc.
8.56%
WuXi Biologics (Cayman), Inc.
8.05%
WuXi AppTec Co., Ltd.
5.79%
Akeso, Inc.
4.67%
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
4.46%
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
4.37%
CSPC Pharmaceutical Group Ltd.
3.77%
Sino Biopharmaceutical Ltd.
3.74%
Genscript Biotech Corp.
3.61%
WuXi AppTec Co., Ltd.
3.36%
Hansoh Pharmaceutical Group Co., Ltd.
2.93%
3SBio, Inc.
2.11%
Yunnan Baiyao Group Co., Ltd.
2.11%
Shanghai United Imaging Healthcare Co., Ltd.
2.08%

Sectors

Healthcare
98.18%
Other
1.82%

Countries

China
82.88%
Switzerland
8.83%
Hong Kong
7.35%
Other
0.94%
Advertisement

Trading data

Last sale
10/30/2026 at 1:30 PM
$17.62
Previous close
$17.80
Consolidated volume
10/29/2026
Join for free
Average volume
30 days
Join for free
Average discount or premium
30 days
Join for free
Average Bid/Ask spread
30 days
Join for free

Volatility and drawdown

3M1Y3Y5Y
Volatility+28.90%+28.05%+26.82%+27.55%
Max drawdown
-10.67%-24.36%-31.17%-58.52%
Max drawdown duration
24d259d619d1804d
Time to recover
N/A113d373dN/A

Replication quality

Data as of September 30, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free
Tracking error
Join for free
Tracking difference
Join for free
1 year cumulative return difference
Best
Join for free
Worst
Join for free
daily return difference
Average
Join for free
Worst
Join for free
Advertisement
Frequently asked questions about KURE

What type of ETF is KURE?

KURE is a Passive ETF that provides exposure to Equity assets. It is managed by KraneShares.

What index does KURE track?

KURE tracks the MSCI China All Shares Health Care 10/40 Index - USD, aiming to replicate its performance through full replication.

What does KURE invest in?

This ETF provides exposure to Large and Mid-Cap Chinese Health Care Equities. It is part of the segment: China Blended Cap.

What is the expense ratio of KURE?

The total expense ratio (TER) of KURE is 0.79%, representing the annual fee charged by the fund manager.

When was KURE launched?

KURE was launched on January 31, 2018, marking its entry into the ETF market.

Who is the issuer of KURE?

KURE is issued by KraneShares.

What is the AUM of KURE?

As of October 30, 2026, KURE manages $107.87 M, reflecting the total assets held in the fund.

How has KURE performed recently?

As of October 30, 2026, KURE delivered a return of -9.54% over the past month (1M performance), 2.04% over the past three months (3M), and 2.21% year-to-date (YTD).

What are the recent fund flows for KURE?

As of October 30, 2026, KURE has seen net flows of +$5M in the past month (1M flow) and +$29M year-to-date (YTD).

Does KURE pay dividends?

As of October 30, 2026, KURE has a trailing 12-month distribution yield of 4.07%.

How many holdings are in KURE

As of September 30, 2026, KURE holds 42 securities in its portfolio. This level of diversification can influence the fund’s risk profile and exposure to individual assets.

How diversified is KURE?

As of September 30, 2026, KURE holds 42 securities, with 68.44% of its assets concentrated in its top 15 holdings.

What are the top holdings of KURE?

As of September 30, 2026, KURE holds a portfolio of 42 underlyings, with its largest positions including BeOne Medicines Ltd., Innovent Biologics, Inc. and WuXi Biologics (Cayman), Inc.. These top holdings play a significant role in shaping the fund’s performance and exposure.

What countries or regions does KURE invest in?

As of September 30, 2026, KURE has its largest geographic exposures in China, Switzerland and Hong Kong.

What sectors or themes does KURE focus on?

As of September 30, 2026, KURE is primarily exposed to Healthcare.

The ETF Institute® is now affiliated with ETF Central

The CETF certification is the only FINRA listed professional designation focused on ETFs.

ETF Institute
Advertisement
Advertisement
ETF U
Become a better investor with NYSE: The Home of ETFs
Visit the ETF U homepage
ETF Guides
Advertisement

Recent educational content

ETF Investing Trends - First Look

First Look ETF

First Look ETF: Income, International, and Cash Flow ETFs

In this season 6 episode of First Look ETF, Stephanie Stanton ‪@etfguide‬ examines the latest ETF marketplace trends with NYSE and guests.

ETF Guide
By ETF Guide · October 20, 2026
Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs October 5, 2026

This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.

Tidal
By Tidal · October 6, 2026
Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs September 28, 2026

This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.

Tidal
By Tidal · September 29, 2026
Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs September 22, 2026

This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.

Tidal
By Tidal · September 23, 2026

Browse all educational columns

Advertisement
New Report

ETFs’ Next Act: From Access to Selection

Global ETF Survey 2026